Mark Crowther Congratulates Mary Cushman on Her Appointment as ISTH President
Mark Crowther, Distinguished University Professor and Chair, Department of Medicine at McMaster University, shared a post on LinkedIn:
“Global Leadership in Thrombosis and Hemostasis: A New Chapter Ahead
The International Society on Thrombosis and Haemostasis (ISTH) has announced the election of Mary Cushman, as International Society on Thrombosis and Haemostasis (ISTH) President for the 2028–2030 term.
Mary Cushman will serve as President-Elect from 2026–2028, working alongside incoming ISTH President Wolfram Ruf, before assuming the presidency at the conclusion of the 2028 ISTH Congress.
Her credentials are exceptional:
- Director, Thrombosis and Hemostasis Program, University of Vermont
- Board Director, Cardiovascular Research Institute
- Co-Director, Vermont Center for Cardiovascular and Brain Health (NIH-funded COBRE)
- 800+ peer-reviewed publications
- 25 guidelines or Society statements
- Mentor to more than 30 research trainees
- Inaugural Editor-in-Chief of Research and Practice in Thrombosis and Haemostasis (RPTH Journal)
This position shapes global research priorities in thrombosis and hemostasis, education, and collaboration in a field central to cardiovascular and thrombotic disease worldwide.
On a personal note, I have known Mary for many years and am fortunate to count her as a friend. She combines intellectual rigour with generosity, strategic clarity with humility, and a deep commitment to mentorship. Those qualities will serve the Society — and our global community — extremely well.
This is outstanding news for International Society on Thrombosis and Haemostasis (ISTH) and for the field.
Congratulations, Mary.
Like, share, and join the conversation.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide
-
Sep 3, 2026, 17:48Isabel Sá: Starting a New Chapter as a Clinical Scientist in Molecular Genetics and Haematology
-
Sep 3, 2026, 17:40Chiwoo Oh: AS01B Adjuvant and Long-Term Immune Reprogramming After Shingrix Vaccination
-
Sep 3, 2026, 17:35Key Developments in Transfusion Medicine and Biotherapies in 2025 – AABB
-
Sep 3, 2026, 17:24N. Mariana S. Vasquez: JAK2 Mutations The High-Yield Map of Myeloproliferative Neoplasms
-
Sep 3, 2026, 17:08Khusi Dhara: Why Women Need to Pay Attention to Iron
-
Sep 3, 2026, 16:54Ralf Ludwig։ Testing Human-Targeted Therapies in a Human Immune System
-
Sep 3, 2026, 16:35Mohsen Salimi: Non-Contrast Chest CT as a Biomarker for Mild-to-Moderate Anemia
-
Sep 3, 2026, 16:10Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia